Keybank National Association Amgen Inc Transaction History

Keybank National Association

$24.1 Billion
Q2 2024

A detailed history of Keybank National Association transactions in Amgen Inc stock. As of the latest transaction made, Keybank National Association holds 185,839 shares of AMGN stock, worth $59.4 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

185,839

Previous 184,337 0.81%

Holding current value

$59.4 Million

Previous $52.4 Million 10.79%

% of portfolio

0.24%

Previous 0.22%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $394,650 - $479,603	1,502 Added 0.81%	185,839 $58.1 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $436,644 - $527,085	1,624 Added 0.89%	184,337 $52.4 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $133,986 - $151,153	524 Added 0.29%	182,713 $52.6 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $495,460 - $615,128	-2,266 Reduced 1.23%	182,189 $49 Million
Q2 2023 Aug 01, 2023	SELL	$214.27 - $253.37 $205,913 - $243,488	-961 Reduced 0.52%	184,455 $41 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $474,384 - $578,195	-2,101 Reduced 1.12%	185,416 $44.8 Million
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $513,714 - $652,735	-2,243 Reduced 1.18%	187,517 $49.2 Million
Q3 2022 Oct 27, 2022	SELL	$224.46 - $253.15 $454,531 - $512,628	-2,025 Reduced 1.06%	189,760 $42.8 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $640,912 - $713,223	-2,778 Reduced 1.43%	191,785 $46.7 Million
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $1.18 Million - $1.3 Million	-5,375 Reduced 2.69%	194,563 $47 Million
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $833,704 - $954,099	-4,192 Reduced 2.05%	199,938 $45 Million
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $961,158 - $1.13 Million	-4,528 Reduced 2.17%	204,130 $43.4 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $2.68 Million - $2.98 Million	-11,492 Reduced 5.22%	208,658 $50.9 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $4.33 Million - $5.05 Million	-19,530 Reduced 8.15%	220,150 $54.8 Million
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $2.42 Million - $2.88 Million	-11,174 Reduced 4.45%	239,680 $55.1 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $2.61 Million - $2.91 Million	-11,144 Reduced 4.25%	250,854 $63.8 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $137,873 - $169,189	-697 Reduced 0.27%	261,998 $61.8 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $1.17 Million - $1.55 Million	-6,406 Reduced 2.38%	262,695 $53.3 Million
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $458,077 - $588,787	-2,421 Reduced 0.89%	269,101 $64.9 Million
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $27,509 - $32,961	158 Added 0.06%	271,522 $52.5 Million
Q2 2019 Aug 01, 2019	SELL	$166.7 - $195.41 $280,889 - $329,265	-1,685 Reduced 0.62%	271,364 $50 Million
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $611,883 - $689,726	-3,383 Reduced 1.22%	273,049 $51.9 Million
Q4 2018 Jan 30, 2019	SELL	$178.4 - $208.25 $1.7 Million - $1.99 Million	-9,553 Reduced 3.34%	276,432 $53.8 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $586,813 - $661,554	-3,167 Reduced 1.1%	285,985 $59.3 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $792,888 - $890,585	-4,775 Reduced 1.62%	289,152 $53.4 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $4.84 Million - $5.66 Million	28,580 Added 10.77%	293,927 $50.1 Million
Q4 2017 Feb 08, 2018	SELL	$168.79 - $188.59 $3.34 Million - $3.73 Million	-19,803 Reduced 6.94%	265,347 $46.1 Million
Q3 2017 Nov 02, 2017	SELL	$167.29 - $191.0 $1.06 Million - $1.21 Million	-6,335 Reduced 2.17%	285,150 $53.2 Million
Q2 2017 May 14, 2018	BUY	N/A	1,437 Added 0.5%	291,485 $50.2 Million
Q1 2017 May 14, 2018	BUY	N/A	1,897 Added 0.66%	290,048 $47.6 Million
Q4 2016 May 14, 2018	BUY	N/A	288,151	288,151 $42.1 Million

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Amgen Inc Transaction History